Jeremy Grantham’s GMO Goes Mainstream With ETF and Mega-Cap Bets

Jeremy Grantham’s valuation-oriented investment firm is famous on Wall Street for trumpeting the contrarian, and decidedly bearish, views of its co-founder, seemingly every passing year.

These days though, the Boston-based money manager is going mainstream by joining the populist ETF boom, with offerings which include expensive-looking tech stocks that Grantham himself has long derided.

After amassing more than $1 billion for its first-ever ETF focusing on US quality stocks that launched last year, Grantham Mayo Van Otterloo introduced a trio of new ETFs in October and plans to debut two more early next year — riding emerging markets and ...